Recent News

• 08.13.2025 - Adaptimmune Reports Q2 Financial Results and Provides Business Update
• 07.28.2025 - Adaptimmune Announces Entry into Definitive Agreement for Sale of TECELRA, lete-cel, afami-cel and uza-cel Cell Therapies to US WorldMeds
• 05.13.2025 - Adaptimmune Reports Q1 Financial Results and Provides Business Update
• 05.07.2025 - Adaptimmune to Report Q1 2025 Financial and Business Updates on Tuesday, May 13, 2025

Recent Filings

• 08.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.13.2025 - EX-99.1 EX-99.1
• 08.13.2025 - 8-K Current report
• 08.07.2025 - 8-K Current report
• 07.31.2025 - 8-K Current report
• 07.31.2025 - EX-99.1 EX-99.1
• 07.30.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.28.2025 - EX-99.1 EX-99.1
• 07.28.2025 - 8-K Current report